DuoNeb
What is COPD?
Do I Have COPD?
Treatment Options
The DuoNeb Advantage
Living Better with COPD
Resources
DuoNeb® combines albuterol and ipratropium, two of the medicines most often prescribed for COPD. Only DuoNeb® has these medications in one simple, easy-to-use medication for your nebulizer.
If you have breathing problems, take our
self-assessment test. Find out if DuoNeb®
is right for you.
Take Control of Your COPD
Improved treatments have helped people with emphysema, chronic bronchitis, or COPD. They can breathe easier and lead more rewarding lives. But how you live your life depends as much on you as on your medicine. It’s about taking control. It’s about being determined. It’s about making the best choices for you.
The more you know about your condition, the better your choices will be. Are you eating well? Are you staying as active as you can? Are you staying involved with friends and family? Have you discussed medication options with your doctor?
 
 
COPD, Chronic Bronchitis and Emphysema
COPD (Chronic
Obstructive Pulmonary
Disease) is a term that covers two lung
diseases:
Chronic bronchitis
A blockage of the
airways that makes it difficult to breathe in.
Emphysema
A breakdown of the air sacs that makes it
difficult to breathe out.
SAFETY INFORMATION   .   PATIENT PRESCRIBING INFORMATION   .   FULL PRESCRIBING INFORMATION
  .   CONTACT US   .   REFERENCES   .   SITE MAP
Please read this important safety information about DuoNeb®
DuoNeb® is indicated for the treatment of bronchospasm associated with COPD for patients requiring more than one bronchodilator. In a 12-week clinical study, the most common adverse reactions reported with DuoNeb® Inhalation Solution were chest pain, pharyngitis, diarrhea, bronchitis, nausea, and leg cramps.
Albuterol sulfate can have a significant cardiovascular effect, significant hypokalemia, and the potential life-threatening paradoxical bronchospasm. Caution is advised in patients with convulsive disorders, hyperthyroidism, diabetes mellitus, narrow-angle glaucoma, prostatic hypertrophy, or bladder-neck obstruction. Co-administration of DuoNeb® Inhalation Solution and other sympathomimetic agents may increase the risk of adverse cardiovascular effects.